Results 201 to 210 of about 1,183,167 (309)

Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives. [PDF]

Hepatol Commun
Brown RS, Brown KA, Flamm S, Bejarano RE, Rahimi RS, Singal AK, Rockey DC.   +6 more
europepmc   +1 more source

Real‐World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM‐POWR Study

European Journal of Haematology, EarlyView.
ABSTRACT Objectives To assess the effectiveness and safety of damoctocog alfa pegol in patients with severe and nonsevere hemophilia A in the fifth interim analysis of the ongoing HEM‐POWR study. Methods HEM‐POWR (NCT03932201) is a multinational, Phase 4, prospective observational study.
Mark T. Reding, María Teresa Alvarez Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg   +7 more
wiley   +1 more source

Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension-Related Bleeding. [PDF]

Liver Int
Talerico R, Pellegrino S, Plessier A, Ponziani FR, Porfidia A, Landi F, Gasbarrini A, Pola R, Santopaolo F.   +8 more
europepmc   +1 more source

Efficacy of the Hong Kong‐Vigilance and Memory Test Platform on Early Detection of Cognitive Deficits and Promotion of Healthy Behaviors in Older Adults

Geriatrics &Gerontology International, EarlyView.
ABSTRACT Introduction The global rise of cognitive impairment and dementia poses significant public health challenges. The Hong Kong‐Vigilance and Memory Test (HK‐VMT) platform combines dementia risk assessment and cognitive tests in one accessible tool to enable early detection of dementia in a community setting.
Ada Wai Tung Fung, Suk Ling Ma
wiley   +1 more source

Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP. [PDF]

Children (Basel)
Sansotta N, De Angelis P, Alberti D, Di Dato F, Arrigo S, Bramuzzo M, Calcaterra B, Cananzi M, Cheli M, Chiaro A, Cirillo F, Colusso M, Di Leo G, Faraci S, Gaio P, Indolfi G, Iuliano S, Liccardo D, Marseglia A, Motta M, Nuti F, Parolini F, Renzo S, Sbravati F, Sciveres M, Mandato C, Di Giorgio A.   +26 more
europepmc   +1 more source

Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease

Hepatology Research, EarlyView.
ABSTRACT Aims Elevated serum free light chain (FLC) and B‐cell activating factor (BAFF) levels have been reported to be associated with B‐cell activation and to serve as biomarkers reflecting disease severity in various diseases. However, limited investigation has been conducted in the context of chronic liver disease (CLD), and the aim of this study ...
Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Hideaki Tanaka, Ryo Nakagawa, Mina Tempaku, Yoshinao Kobayashi, Hayato Nakagawa   +8 more
wiley   +1 more source

Use of Partial Splenic Embolization Following a Transjugular Intrahepatic Portosystemic Shunt to Reduce Persistent Portal Hypertension Sequelae. [PDF]

Cureus
Schultz G, Naas M, Webb J.
europepmc   +1 more source

Fibulin Family Members: New Players in Liver Fibrosis and Potential Biomarkers in Chronic Liver Diseases

Hepatology Research, EarlyView.
ABSTRACT Chronic liver diseases (CLD) arising from various etiologies including viral hepatitis, excessive alcohol intake, alcoholic associated liver disease (ALD) and metabolic dysfunction‐associated steatotic liver disease (MASLD), are associated with persistent hepatic injury ultimately resulting in fibrosis.
Fidaa Bouezzedine, Célia Thomas, Nathalie Théret   +2 more
wiley   +1 more source

A Rare Case of Idiopathic Noncirrhotic Portal Hypertension in a Young Patient. [PDF]

Cureus
Aziz AA, Aziz MA, Amir M, Shah R, Ali IA.   +4 more
europepmc   +1 more source